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Polymorphonuclear  leucocytes obtained  from  acute  peritoneal exudates  in 
rabbits are capable, when appropriately stimulated, of producing large amounts 
of endogenous pyrogen (1-3). There is mounting evidence that this pyrogenic 
factor plays an important role in the pathogenesis of fever (4, 5). Exploratory 
studies relating to the production of leucocytic pyrogen in vitro have revealed 
that the process is temperature-dependent and  that it results in a  substantial 
net increase of active pyrogen per cell during  incubation in saline  (2).  Since 
these findings are in keeping with  the  hypothesis  that  the  active pyrogen is 
formed,  either from an inactive precursor or by de novo synthesis within the 
cell, experiments were undertaken to investigate the possible effects of certain 
enzyme  inhibitors  upon  the  combined  metabolic  reactions  involved  in  the 
formation and release of the pyrogen. 
Methods 
The technical procedures employed in obtaining appropriate quantifies of rabbit granulo- 
cytes from acute peritoneal exudates and in  assaying the endogenous  pyrogen which  they 
produce during incubation in saline were identical with those of the preceding study (2). The 
standard aliquot of granulocytes used in aU experiments contained 3.5 ×  108 polymorphonu- 
dear leucocytes from 12 to 18 hour peritoneal exudates.  All cell suspensions  or extracts to 
which enzyme inhibitors or activators had been added were brought to neutrality before being 
incubated, unless  otherwise  stated. After incubation, the samples to be assayed for pyro- 
genicity were dialyzed in ceUophane tubing against a minimum of 30 volumes of saline at 4°C 
for 20 hours. Three changes of saline were made during each dialysis. 
RESULTS 
Sulfhydryl Reagents.- 
Each of four standard aliquots of granulocytes  harvested from 18 hour exudates was washed 
in 30 ml of cold normal saline  x and was resuspended in 11.7 ml (3 X  l0  T  ceils per ml) of saline 
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1 When unwashed cells were used, results were irregular. 
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containing a final concentration of 2 X  10  -4 M  of one of the four sulfhydryl reagents listed in 
Table L The mixtures of cells and reagents were incubated at 37°C for 4 hours, following 
which the  cells were separated  by centrifugation  at 4°C, and the  supernatant fluids were 
dialyzed against cold saline and tested for pyrogenicity. The results are recorded in Table I. 
When exposure of the cells to the reagents was prolonged to 20 hours at 37°C, similar results 
were obtained. 
To determine the possible effect of the sulfhydryl reagents upon the pyrogen 
molecule itself, analogous experiments were performed  using pyrogen already 
released from granulocytes, rather than suspensions of  the cells. Each  aliquot 
of preformed pyrogen consisted of the supernatant from a  saline-cell mixture 
containing one standard aliquot of cells (3.5  X  10  s)  incubated at  37°C  for 4 
hours. As indicated in Table II, the reagents were added  in concentrations of 
TABLE I 
Effect  of Sulfhydryl  Reagents  on  Production  of Endogenous  Pyrogen  by Intact  Granulocytes 
Inhibitor  Concentration  of  Pyrogen produced 
inhibitor*  (mean fever index~) 
None (control) ..................... 
Arsenite ........................... 
Iodoacetate ........................ 
p-chloromercuribenzoate  ............. 
N-ethylmaleimide ................... 
0 
2  X  10  -4 M 
2  X  10-4M 
2  X  10-4M 
2 X  10-4~ 
22.8 
2.1 
2.3 
3.1 
0.5 
(2.53) 
(0.56) 
(2.12) 
(1.13) 
(0.71) 
(4) 
(6) 
(2) 
(2) 
(4) 
* Exposure of cells to inhibitor: 4 hours at 37°C. 
~: Fever index =  measure of height and duration of febrile response as indicated by area 
beneath fever curve (6). Figures in parentheses  =  standard deviations (]eft) and number of 
observations on which mean value was based (right). 
2 X  10  -4 ~  and 1 X  10  -2 M and were incubated with the pyrogen for a period 
of 4 hours. Additional experiments, in which the exposure time was prolonged 
to 20 hours, yielded essentially identical data. 
The results summarized in Tables I  and II indicate: (a)  that relatively low 
concentrations of arsenite, iodoacetate, p-chloromercuribenzoate, and N-ethyl- 
maleimide (i.e.,  2  X  10-4 ~r) inhibited the production of endogenous pyrogen 
by intact leucocytes, (b) that none of them grossly affected  2 the activity of the 
preformed pyrogen at these concentrations, and (c)  that at higher concentra- 
tions (1  X  10  -2 M)  only the iodoacetate inactivated the preformed pyrogen, 
even when the exposure time was prolonged to 20 hours. 
Glutathione.--Because  the  above compounds suppressed the  production of 
leucocytic pyrogen, experiments were performed to determine whether reduced 
2 Since the fever index on the untreated sample was >  20, i.e., in the relatively insensitive 
range of the assay procedure (2), partial inactivation of the pyrogen could have occurred 
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glutathione would enhance it. On the contrary as shown in Table III, the gluta- 
thione exerted a striking inactivating effect of its own. Since this effect did not 
occur at 4°C and required several hours to reach completion, it was tentatively 
attributed to a degradation of the pyrogen by an enzymatic process activated 
TABLE  II 
Effect  of Sulfhydryl  Reagents on  Thermogenic Activity  of Preformed  Granulocytic Pyrogen 
None (control) 
Arsenite 
Iodoacetate 
p-chlormercuribenzoate 
N-ethylmaleimide 
Inhibitor  Concentration of  Activity of pyrogen 
inhibitor*  (mean fever index~) 
0 
2  X  10--*M 
1  X  10-*~ 
2X  10"-* M 
1  X  10-*~ 
2  X  10-4M 
1  X  10-*M 
2  X  10  -* M 
1  X  10  -~ 
22.8 
20.8 
18.1 
20.8 
3.4 
20.1 
20.2 
23.8 
21.4 
(2.53) 
(3.46) 
(0.35) 
(o. 28) 
(o. 85) 
(3.94) 
(4.65) 
(3.70) 
(5.93) 
(4) 
(2) 
(2) 
(2) 
(2) 
(3) 
(6) 
(2) 
(2) 
* Exposure  of  pyrogen  to  inhibitor:  4  hours  at  37°C. 
As in Table I. 
TABLE  III 
Gross Inactivating  Effect  of Glutathione on  Crude Preparations  of Leucocyti~ Pyrogen 
Concentration of glutathione  Incubation  temperature*  Activity of pyrogen~: 
2  X  10-* 
2  X  10  -8 M 
2  X  10-2~ 
2  X  10--2 ~ 
°c 
37 
37 
37 
0 
++ 
+ 
0 
++ 
* Incubation time, 20 hours. 
+  +  =  full pyrogeuic activity, +  =  depressed activity, 0  -- no activity. 
by the presence of the glutathione. When the experiments were performed with 
partially purified leucocytic pyrogen (7) from which much of the non-pyrogenic 
protein had been removed, the gross degradation did not occur. If, however, 
crude pyrogen was incubated with purified pyrogen in the presence of gluta- 
thione, the mixture was inactivated (see Table IV). It was concluded, therefore, 
that proteases, present in the crude leucocytic extracts (8, 9) and activated by 
reduced sulfhydryl groups (10), were probably destroying the active pyrogen. 40  PATHOGENESIS  0~' FEVER.  X 
To test this hypothesis further, four standard aliquots of preformed teuco- 
cytic pyrogen (ride supra) were handled in the following manner. 
Aliquot 1  was stored at 4°C, while aliquot 2 was incubated at 37°C for 20 hours. Gluta- 
thione, in a  final concentration of 2  X  10  -~ ~, was added to aliquots 3 and 4,  which there- 
after were treated like 1 and 2, respectively. To determine the degree of proteolysis occurring 
TABLE  IV 
Comparative Inactivating Effects of Glutathione on Crude and Partially Purified Preparations 
of Lencocytic Pyrogen 
Concentration of  Pyrogenic activity* 
Preparation of pyrogen  glutathione  (mean fever index$) 
Crude 
"Purified" 
"Purified" plus crude 
0 
2 X  10  -~ M 
0 
2X  10-~M 
0 
2  X  10  -2 M 
17.2 
0.7 
18.0 
15.8 
24.3  I 
3.9 
(2.20) 
(0.30) 
(2.46) 
(0.39) 
(5.16) 
(1.33) 
(3) 
(3) 
(3) 
(2) 
(3) 
(3) 
* After  incubation  for  20  hours  at  37°C. 
As in Table  I. 
TABLE  V 
Concentrations of  280 m# Absorbing A rid-Soluble, Proteolytic Products in Preparations of Crude 
Leucocyti¢ Pyrogen Incubated with and without Added Glutathione 
Time of incubation  Concentration glutathione added  Optical density (280 m/~)* 
hrs.  at 37°C 
0 
20 
0 
20 
0 
0 
2  X  10-~M 
2X  10--~  M 
0.501 
0.526 
0.593~ 
0.936 
* Measured  on  supernatant  fluids of  perchloric acid  precipitate. 
$ Glutathione  itself  raises  OD  (280  rag)  slightly  when  added  in 
2 X  10-  2 ~t (7). 
concentration  of 
at 37°C in both the presence and absence of added glutathione, 0.5 ml of 60 per cent perchloric 
acid was added to a 5.8 ml sample of each aliquot, which was then stored at 0°C for 2 hours, 
centrifuged in the cold to remove the precipitated protein, and measured for optical density 
at 280 m/~ in a Beckman DU spectrophotometer. 
The results recorded in Table V indicate that the concentration of acid-soluble 
peptides and amino acids increased substantially during the incubation with 
added glutathione.  This finding  is in keeping with the postulated increase in 
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Finally,  it is  of interest  that concentrations of glutathione  (2  X  10  -1 ~), 
which will often reduce disulfide bonds (11)  at 37°C, had no demonstrable in- 
activating effect upon the purified pyrogen even after 6 hours. This finding is 
in agreement with the observation that exposure to 1.6  X  10  -1 ~  bisulfite at 
4°C for 4 hours also does not inactivate the pyrogen molecule (12). 
Diisopropyl  Fluorophosphate.--In  an  attempt  to block the  proteolytic en- 
zymes activated by the glutathione,  preliminary experiments were performed 
in which diisopropyl fluorophosphate (DFP) was introduced into the system. 
This compound, however, was found to have a  definite inhibitory effect upon 
the activity of preformed leucocytic pyrogen (see Table VI). 
TABLE VI 
Effect of Diisopropyl Fluorophosphate (DFP)  on Activity of Leucocyti~ Pyrogen 
Concentration 
of DFP 
1X I0-4~ 
1 X  lO-3M 
3 X 10  -a ~t 
5 X 10  -au 
1  X  10  -s 
1  X  10  '~u 
1  X  10-4M 
5× lO-4M 
1  X  10  -a ,s 
Pyrogen preparation 
Crude 
Crude 
"Purified" 
cc 
Duration of 
Incubation 
hrs. 
6 
6 
6 
6 
6 
20 
Incubation 
temperature 
37 
37 
37 
37 
37 
4 
37 
37 
37 
Activity of pyrogen 
(mean fever index*) 
.5.8  (2.40)  (3) 
~6.0  (4.40)  (3) 
2.4  (1.51)  (4) 
0.3  (0.32)  (4) 
0.3  (0.35)  (2) 
~5.7  (--)  (1) 
~3.9  (3.27)  (4) 
4.2  (1.75)  (3) 
2.6  (1.81)  (3) 
* As in Table I. 
Each aliquot of preformed pyrogen was prepared by incubating 3.5 X  108 exudate leuco- 
cytes in saline at 37°C for 4 hours, removing  the cells by ceutrifugation, and diluting the super- 
natant to a volume of 11.7 ml with additional saline and the appropriate amount of DFP in 
propylene glycol. The stock solution of DFP was prepared at a concentration of 0.05 M  in 
propylene glycol.  The latter solvent was shown to have no effect  by itself in concentrations  of 
20 per cent when  incubated with the pyrogen  at 37°C for 20 hours. 
It will be noted from the data recorded in Table VI that the inactivation of 
pyrogen by DFP did not occur at 4°C and that the partially purified pyrogen 
was more sensitive to inactivation than the crude pyrogen. Raising the pH of 
the incubation mixture to 8 did not increase the sensitivity of crude pyrogen 
to DFP (13). 
Attempts to protect the pyrogen from the inactivating effect of DFP by first 
adding the known antagonist, 2-pyridine aldoxime methiodide (2-PAM) (14), 
to the incubation mixture were unsuccessful (see Table VII). Indeed the 2-PAM 
appeared to potentiate the DFP rather than block its effect (15).  Nor did the 42  PATttOGENESIS  O1  e  FEVER.  X 
2-PAM  reactivate DFP-treated  pyrogen when added after the excess DFP  had 
been removed  by dialysis.  Likewise,  hydroxylamine  failed  to reactivate DFP- 
treated pyrogen even when added in concentrations as high as  1 ~  and kept in 
contact  with  the  dialyzed  DFP-pyrogen  complex  for  as  long  as  48  hours  at 
37°C,  or 3  weeks  at 4°C. 
TABLE  VII 
Gross Effect of Diisopropyl Fluorophosphate (DFP)  on Activity of Crude Leucocytic Pyrogen in 
Presence of DFP Antagonists: 2-Pyridine  aldoxime methiodide (2-PAM) and 
Hydroxylamine  (HA) 
Concentration  of DFP 
0 
1  X  10  -8 M 
1  X  10  -3 M 
1  X  10-sM 
1  X  10-8:~ 
3  X  10-~ 
3  X  10  -3 M 
3  X  10-~ 
0 
3  X  10 -3 M 
3  X  10-3M 
3  X  10-3~ 
3  X  10  -3 
Protection* 
2-PAM,  10  -2 
2-PAM,  10  -5 
2-PAM, 10  -4 
2-PAM, 10  -3 
HA, 1 
Reactivation+* 
2-PAM, 10  -2 ~t 
2-PAM, 10  -2 
HA, 1 
HA,  1 
HA,  1 ~[ 
20 hrs. 
6 hrs. 
6 hrs. 
6  " 
6  " 
6 hrs. 
6 hrs. 
30  " 
6 hrs. 
6 hrs. 
6 hrs. 
48  " 
3 wks. 
Incubation ~  Duration of  I ryrogemc 
iocubation  t~r  a~ti,  i~y~ 
37  ++ 
37  + 
37  0 
37  0 
37  0 
37  0 
37  0 
37  +  + 
37  0 
37  0 
37  0 
4  0 
* Added  before  incubation  with  DFP. 
/  Added after incubation with DFP and removal of excess DFP  by dialysis. 
§ As in Table III. 
Dinitrofluorobenzene.--Inasmuch  as  2,4-dinitrofluorobenzene  (DNFB)  is 
known  to inactivate certain DFP-sensitive  enzymes (16,  17),  its action on leu- 
cocytic pyrogen was also tested. 
Aliquots of leucocytic pyrogen, each of which contained the amount produced by 3.5 X  108 
exudate granulocytes during incubation at 37°C for 4 hours in 7 ml of saline, were diluted with 
3.5 ml of 0.05 ~ phosphate buffer adjusted to pH 8.  To each aliquot was added  1.16 ml of a 
solution  of  DNFB  in  propylene  glycol.  The  final  concentration  of  DNFB  in  the  pyro- 
gen samples varied from 10  -4 to 10  -2 ~. Each sample was incubated at 37°C, dialyzed against HANS  KLAUS  KAISER  AND  W.  BARRY  WOOD,  JR.  43 
normal saline, and tested for pyrogenicity. The incubation times varied between 15 minutes 
and 6 hours. Control experiments with 20 per cent propylene glycol and phosphate buffer 
showed that neither of these reagents affected the activity of the pyrogen. 
It will be seen from the results recorded in Table VIII, that DNFB  inac- 
tivates leucocytic pyrogen at concentrations even lower than DFP, Decreasing 
the pH of the medium from 8 to 6.5 suppresses the inactivating effect of the 
DNFB. This finding is in agreement with similar experiments relating to the 
action of DNFB on chymotrypsin (17). The characteristic yellow chromogens, 
which result from the reaction of DNFB with free amino groups, regularly ap- 
TABLE VIII 
Gross Effect of 2,4-Dinitrofluorobemene  DNFB)  on Activity  of Leucocytic Pyrogen 
Concentration of DNFB  pH  Duration of incubation*  Activity of pyrogen:~ 
10  -4 
5  X  10  -4 ~t 
20 hrs. 
6 hrs. 
6  " 
++ 
+4- 
0 
I0  -a M 
10  -3 
10-  ~ 
10  -2 
I0-~ 
8 
8 
8 
8 
6.5 
6  ~ 
lhr. 
15 rain. 
6 hrs. 
6 hrs. 
0 
+ 
++ 
0 
++ 
* At  37°C. 
:~ As in Table III. 
peared after about 20 minutes of incubation (18). The proportion of chromogen 
formed by the interaction of DNFB with the pyrogen could not, of course, be 
distinguished from that resulting from the reaction of DNFB with other pro- 
teins in the crude preparation. 
DISCUSSION 
That the production of leucocyfic pyrogen involves metabolic reactions of the 
cell,  rather  than  a  mere  "leakage"  of  a  preformed intracellular  constituent 
through an altered cell membrane, is indicated by the observations recorded in 
the preceding report (2). In keeping with these observations is the fact that the 
sulfhydryl-reactive enzyme inhibitors used in the present experiments blocked 
the production of leucocytic pyrogen, when incubated with the cells in a con- 44  PATHOGENESIS  OF  ~'EVER.  X 
centration of 2 X  10  -~ ~.8 It should be noted, however, that one of the inhibitors, 
iodoacetate, also inactivated the pyrogen molecule itself, at a concentration of 
1 X  10  -2 ~. This finding complicates the interpretation of the first observation 
in the case of iodoacetate, since it may be argued that the apparent interference 
with the production process may have been due to an intracellular inactivation 
of the preformed pyrogen by iodoacetate concentrated in the cell. Such a~a ex- 
planation, however, seems less reasonable in the case of the other sulfhydryl 
reagents  (arsenite,  p-chloromercuribenzoate,  and  N-ethylmaleimide),  since 
none of them inactivated the pyrogen at a concentration 50 times that  which 
blocks production of pyrogen by the intact cells.  Thus it may be tentatively 
concluded that the latter compounds exert their blocking effects by interfering 
with cellular reactions essential to pyrogen production. 
The finding that preformed leucocytic pyrogen is relatively sensitive to the 
inactivating  effects of diisopropyl fluorophosphate and  dinitrofluorobenzene 
raises interesting questions concerning the chemistry of the pyrogen molecule. 
Since there is already evidence that the pyrogen is either itself a protein or else 
is a macromolecule containing an essential protein constituent (7, 20), and since 
both DFP and DNFB inactivate certain enzymes by combining with specific 
reactive groups of the enzyme molecules (14,  17, 21, 22) and DNFB partially 
inactivates placental gonadotropic hormone (23), the possibility must be enter- 
tained that leucocytic pyrogen functions either as an enzyme or as a hormone 
and that it possesses specific reactive groups which are blocked by these in- 
hibitors. The failure to reverse or block the inactivating effect of DFP with its 
antagonists, 2-pyridine aldoxime methiodide and hydroxylamine, indicates that 
the action of DFP on leucocytic pyrogen differs from its action on acetylcholin- 
esterase (14, 24). Nevertheless, the demonstrations of interactions of leucocytic 
pyrogen with DFP and DNFB provide provocative leads which warrant further 
investigation. 
The manner in which the higher concentrations of iodoacetate (I X  10  -2 ~) 
inactivate the pyrogen molecule is not clear, in view of the failure of equal con- 
centrations  of  arsenite,  p-chloromercuribenzoate,  and  N-ethylmaleimide  to 
exert the same effect. The fact that the pyrogen is capable of withstanding ex- 
posure to  1 X  10  -2 ~r concentrations of the latter inhibitors at 37°C  for 20 
hours, makes it unlikely that the thermogenic action of the pyrogen molecule 
is dependent upon the presence of free sulfhydryl groups  (25). It is possible, 
therefore, that the inactivating effect of the iodoacetate is due to its known 
influence upon reactive protein groups other than sulfhydryl radicals (26). 
The experiments dealing with glutathione are of interest in two regards. First, 
the failure of glutathione to inactivate partially purified leucocytic pyrogen, 
even at concentrations as high as 2 X  10  -'1 ~, suggests that the pyrogen mole- 
3  These same reagents are also known to affect the carbohydrate metabolism of polymorpho- 
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cule does not possess disulfide bonds essential for activity (11). This suggestion 
is supported by the results of analogous experiments  performed with bisulfite 
(12). Neither observation, however, can be considered to be conclusive. Second, 
the demonstration that leucocytes  incubated in saline release proteolytic en- 
zymes, which are apparently capable of degrading the pyrogen molecule when 
activated by glutathione, reveals a potential mechanism whereby the pyrogen 
may be destroyed in ~vo.  Such a reaction might thus contribute to deferves- 
cence. Although there is at present no evidence that the proteolytic mechanism 
actually operates under the conditions which pertain in inflammatory  exudates, 
it is of interest that polymorphonuclear leucocytes contain detectable amounts 
of reduced glutathione (27, 28). 
SUMMARY 
The production of endogenous pyrogen by intact granulocytes obtained from 
acute peritoneal exudates is blocked by arsenite, iodoacetate,  p-chloromercuri- 
benzoate, and N-ethylmaleimide in concentrations of 2 X  10  -4 ~. 
When the concentration of these sulfhydryl-reactive enzyme inhibitors is in- 
creased to 2 X  10  -'* ~, only the iodoacetate inactivates the pyrogen molecule, 
whereas the arsenite,  the p-chloromercuribenzoate,  and the N-ethylmaleimide 
have no gross effect upon its thermogenic activity. 
Both diisopropyl  fluorophosphate  and dinitrofluorobenzene  are even more 
potent inactivators of the pyrogen molecule than iodoacetate, although the 
action of the DFP cannot be blocked or reversed by known antagonists such as 
2-pyridine aldoxime methiodide and hydroxylamine. 
Proteolytic enzymes, potentially capable of degrading leucocytic pyrogen, are 
released  from polymorphonuclear leucocytes,  along  with the pyrogen, when 
the cells are incubated in normal salt solution. These enzymes are readily ac- 
tivated by a sufficient concentration of glutathione (2 X  10  -~ ~). They are not 
present in preparations of partially purified leucocytic pyrogen from which much 
of the non-pyrogenic protein has been removed. 
Glutathione by itself, even at concentrations as high as 2 X  10  -I ~, does not 
affect in the gross the thermogenic activity of the purified pyrogen. 
The implications of these findings in relation to both the production and the 
chemical characteristics  of leucocytic pyrogen are discussed. 
BIBLIOGRAPHY 
1.  King, M. K., and Wood, W.  B., Jr.,  Studies on the pathogenesis of fever. III. 
The leucocytic origin of endogenous pyrogen in acute inflammatory exudates, 
J. Exp.  Med., 1958, 107, 279. 
2.  Kaiser, H. K., and Wood, W. B., Jr., Studies on the pathogenesis of fever. IX. 
The  production of  endogenous pyrogen by  polymorphonuclear leucocytes, 
J. Exp. Med., 1962, 115, 27. 
3.  Fessler, J. H., Cooper, K. E., Cranston, W. I., and Vollum, R. L., Observations 46  PATHOGENESIS  OF  :FEVER.  X 
on the production of pyrogenic substances  by rabbit and human leucocytes, 
J. Exp.  Mad.,  1961, 113,  1127. 
4.  Wood, W.  B., Jr., The genesis of fever in infectious  disease, in Immunity and 
Virus Infection, (V. A. Najjar, editor), New York, John Wiley and Sons, Inc., 
1959,  144-162. 
5.  Atkins,  E., Pathogenesis  of fever, Physiol.  Ray., 1960, 40, 580. 
6.  GiUman, S. M., Bornstein, D. L., and Wood, W. B., Jr., Studies on the pathogene- 
sis of fever. VIII. Further observations  on the role of endogenous pyrogen in 
endotoxin fever, 3". Exp. Mad.,  114, 729. 
7.  Rafter, G. W., Collins, R. D., and Wood, W. B., Jr., Studies on the pathogenesis 
of fever.  VII.  Preliminary chemical  characterization of leucocytic pyrogen, 
J. Exp.  Mad.,  1960, 111,  831. 
8.  Surer,  E.,  Interaction  between  phagocytes  and  pathogenic  microorganisms, 
Bacterial. Ray., 1956, 20,  95. 
9.  Mounter, L.  A., and Atiyeh, W.,  Proteases  of human leukocytes, Blood, 1960, 
15, 52. 
10.  Fruton, J.  S.,  Cathepsins,  in The Enzymes, (P.  D.  Bayer, H.  Lardy, and  K. 
Myrb~tch, editors),  New York, Academic Press,  1960, 4, 233. 
11.  Calvin, M., Mercaptans and disulfides: some physics, chemistry and speculation 
in Glutathione, a Symposium, New York, Academic Press,  Inc., 1954, 3. 
12.  Rafter, G. W.,  unpublished  data. 
13.  O'Brien, R. D., Toxic Phosphorus Esters, New York, Academic Press, Inc., 1960, 
80. 
14.  Wilson,  I.  B.,  Molecular  complementarity and  antidotes  for alkalyphosphate 
poisoning,  Fed.  Proc.,  1959, 18,  752. 
15.  Hackley, B.  E., Jr.,  Steinberg,  G.  M.,  and Lamb, J.  C.,  Formation of potent 
inhibitors of AChE  by reaction of pyridinaldoximes  with  isopropyl  methyl- 
phosphorofluoridate  (GB), Arch.  Biochem. and Biophysics,  1959, 80, 211. 
16.  Whitaker, J. R., and Jandorf, B., Specific reactions  of dinitrofluorobenzene  with 
active groups of chymotrypsin, J. Biol.  Chem., 1956, 223, 751. 
17. Sturtevant, J. M., The mechanism  of action of chymotrypsin, in Protein Struc- 
ture and Function, report of symposium,  Upton, New York, Brookhaven Na- 
tional Laboratory, 1960, 151. 
18.  Fruton, J. S., and Simmonds, S., General Biochemistry,  New York, John Wiley 
& Sons, Inc.,  1959, 142. 
19.  Cohn, Z. A., and Morse,  S. I., Functional and metabolic properties of polymor- 
phonuclear leucocytes.  I. Observations  on the requirements and consequences 
of particle ingestion, J. Exp. Med., 1960, 111, 667. 
20.  Rafter, G. W., Collins, R. D., and Wood, W. B., Jr., The chemistry of leukocytic 
pyrogen, Tr. Assn. Am. Physn.,  1959, 72, 323. 
21.  Wilson, I. B., in The Enzymes, (P. D. Bayer, H. Lardy, and K. Myrb/ick, editors), 
New York, Academic Press,  Inc.,  1960, 4, 501. 
22.  Bender, M.  L., Mechanisms  of catalysis  of nucleophi!ic reactions  of carboxylic 
acid derivatives,  Chem. Rev., 1960, 60, 53. 
23.  Bourillon,  R.,  Got, R., and Marcy, R.,  Stabilit6  de la gonadotrophine  choriale 
humaine sous l'effet d'agents chimique, Bul. Sac. ehim. biol., 1959, 41,345. HANS KLAUS KAISER AND W.  BARRY WOOD, JR.  47 
24.  Grob, D., and Johns, R. J., Use of oximes in the treatment of intoxication by anti- 
cholinesterase compounds in normal subjects, Am. J. Med., 1958, 24, 497. 
25.  Chinard, F. P., and Hellerman, L., Determination of sulfhydryl groups in certain 
biological substances, in Methods of Biochemical Analysis,  (I). Glick, editor), 
1954,  1,  1. 
26.  Michaelis, L., and Schubert,  M.  P., The reaction of iodoacetic acid on mercap- 
tans and amines, J. Biol. Chem., 1934, 106, 331. 
27.  Hardin, B., Valentine, W. N., Follette, J. H., and Lawrence, J.  S., Studies on the 
sulfhydryl  content  of human  leucocytes and  erythrocytes,  Am.  J.  Med.  Sc., 
1954,  9.28, 73. 
28.  Pisciotta,  A.  V.,  and  Daly,  M.,  Studies  on  agranulocytosis.  III. The  reduced 
glutathione  (GSH)  content  of leukocytes  of normals  and  patients  recovered 
from agranulocytosis, Blood, 1960,  16,  1572. 